July 27, 2017 4:19 AM ET

Biotechnology

Company Overview of Altimmune, Inc.

Executive Profile

Mitchel B. Sayare Ph.D.

Director, Altimmune, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.

See Board Relationships
69--

Background

Dr. Mitchel B. Sayare, also known as Mitch, Ph.D. served as the Chief Executive Officer of ImmunoGen Inc. (a biotechnology company) from 1986 to January 1, 2009 and as its President from 1994 to July 29, 2008. From 1986 to 1992, Dr. Sayare served as the President of ImmunoGen Inc. From 1982 to 1985, Dr. Sayare served as a Vice President of Development at Xenogen Inc. Dr. Sayare has been the Chairman of PharmAthene, Inc. since July 15, 2011. Dr. Sayare served as the Chairman ...

Corporate Headquarters

19 Firstfield Road
Gaithersburg, Maryland 20878

United States

Phone: 240-654-1450
Fax: --

Board Members Memberships

Director
2017-Present
Director

Education

Bachelor's Degree
Ursinus College
PhD
Temple University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Daniel J. Abdun-Nabi Chief Executive Officer, President and Director
Emergent BioSolutions Inc.
$776.6K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Altimmune, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.